Imagine a time when all your teams collaborate seamlessly. That’s what this year’s Veeva Commercial Summit posited as it commenced. Chris Moore, president of Veeva Europe, opened the conference – the ...

The deal signals Veeva’s push to expand artificial intelligence tools that help pharmaceutical brands interact with patients and healthcare professionals. The transaction adds an AI-powered engagement ...

Veeva's laser focus on the life sciences industry has made it a leader in this corner of the cloud market. The company could grow its revenue -- and share price -- at a good clip in the next four ...

BioDlink previously announced the successful go-live of Veeva QMS, bringing four core quality processes onto Veeva’s cloud-based, life-sciences-specific platform as part of its broader digital quality ...

Artificial intelligence and related technologies are evolving rapidly, but until recently, Java developers had few options for integrating AI capabilities directly into Spring-based applications.

Veeva Systems is rated a buy, with strong revenue and EPS growth, raised FY2026 guidance, and a misunderstood sell-off creating a long-term opportunity. VEEV's migration to Vault CRM is progressing ...

At the 2025 Veeva Commercial Summit Europe, industry members touted the current and future potential of AI in the life sciences sector. Image credit: Veeva Systems. At the 2025 Veeva Commercial Summit ...

Veeva Systems (VEEV) reported strong Q3 results, but slowing growth and declining ROIC raise concerns about its competitive edge and valuation. VEEV's robust balance sheet and industry specialization ...

Veeva Systems Inc. (NYSE:VEEV) is one of the best digital health stocks to buy now. On November 4, 2025, Veeva announced that its Veeva Basics solution has been adopted by “more than 100 biotechs” to ...